ASM to host Investor Day on September 23, 2025
Get Alerts ASM Hot Sheet
Join SI Premium – FREE
Almere, the Netherlands
August 28, 2025
ASM International N.V. (Euronext Amsterdam: ASM) will host its Investor Day on September 23, 2025, in London, UK.
ASM’s Investor Day will provide a comprehensive update on the company’s performance and strategic direction, with a focus on how its Growth through Innovation strategy continues to deliver value for all stakeholders. Presenters will include Hichem M’Saad, CEO, Paul Verhagen, CFO, and other members of our senior management team. The formal program will start at 1:30 p.m. BST and conclude at approximately 5:00 p.m. BST. A detailed agenda will be shared closer to the event via the ASM Investor Day website.
The event will take place at the Pan Pacific hotel in London. In view of capacity limitations, registration is required. Institutional investors and analysts interested in attending in person are invited to contact us at: [email protected].
The presentations and Q&A can also be followed through a live listen-only webcast available at ASM Investor Day.
About ASM International
ASM International N.V., headquartered in Almere, the Netherlands, and its subsidiaries design and manufacture equipment and process solutions to produce semiconductor devices for wafer processing, and have facilities in the United States, Europe, and Asia. ASM International's common stock trades on the Euronext Amsterdam Stock Exchange (symbol: ASM). For more information, visit ASM's website at www.asm.com.
| Contacts | |
| Investor and media relations | Investor relations |
| Victor Bareño | Huiying Jing |
| T: +31 88 100 8500 | T: +31 88 100 8124 |
| E: [email protected] | E: [email protected] |
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NINGJI Takes Centre Stage at KLCC, Strengthening Its Position as a Benchmark for Southeast Asian Expansion Through Five Key Localization Strategies
- HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Can
- Rocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit, Supporting Globalstar Direct-to-Device Communications Services
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share